RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study
Clinical trial NCT06790420 · COMPLETED
Trial details
- NCT number
- NCT06790420
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2025-01-31
- Primary completion
- 2025-03-14
- Enrollment
- 2703
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.